Identification of conserved aromatic residues essential for agonist binding and second messenger production at 5-hydroxytryptamine(2A) receptors

Molecular Pharmacology

Volumn 52, Issue 2, 1997, Pages 259-266

  Roth, B L ^a,b   Shoham, M ^a   Choudhary, M S ^a   Khan, N ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Dept of Biochemistry ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,5 DIMETHOXY 4 METHYLAMPHETAMINE; ALPHA METHYLSEROTONIN; AROMATIC AMINO ACID; BUFOTENINE; GUANINE NUCLEOTIDE BINDING PROTEIN; KETANSERIN; MIANSERIN; PHOSPHATIDYLINOSITOL; RADIOLIGAND; SEROTONIN 2A AGONIST; SEROTONIN 2A RECEPTOR; SPIPERONE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL STRAIN COS1; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG EFFICACY; DRUG POTENCY; DRUG RECEPTOR BINDING; GENE EXPRESSION; LIGAND BINDING; MOLECULAR MODEL; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; POINT MUTATION; PRIORITY JOURNAL; SECOND MESSENGER;

EID: 0030742276     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.2.259     Document Type: Article

References (33)

1. 1c receptors. Mol. Pharmacol. 42:627-633 (1992)
2. 2 receptors. Mol. Pharmacol. 43:755-763 (1993)
3. 2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding. Mol. Pharmacol. 47:450-457 (1995).
4. 2 receptors. Handb. Exp. Pharmacol., in press.
5. 2A receptor. J. Biol. Chem. 271:14672-14675 (1996).
6. Johnson, M. P., R. J. Loncharich, M. Baez, and D. L. Nelson. Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines. Mol. Pharmacol. 45:277-286 (1994).
7. Henderson, R., J. Baldwin, T. H. Ceska, F. Zemlin, E. Beckmann, and K. Downing. Model for the structure of bacteriorhodopsin based on high resolution electron cryomicroscopy. J. Mol. Biol. 213:899-929 (1990).
8. Schertler G. F. X., and P. A. Hargrave. Projection structure of frog rhodopsin in two crystal forms. Proc. Natl. Acad. Sci. USA 92:11578-11582 (1995).
9. 2 receptor. Mol. Brain Res. 14:166-176 (1992).
10. 2 receptor. Med. Chem. Res. 3:370-385 (1993).
11. Hibert, M. F., S. Trumpp-Kallmeyer, A. Bruinvels, and J. Hoflack. Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. Mol. Pharmacol. 40:8-15 (1991).
12. 2c receptor interactions. Eur. J. Pharm. 306:195-210 (1996).
13. Nakayama, T. A., and H. G. Khorana. Mapping of the amino acids in membrane-embedded helices that interact with the retinal chromophore in bovine rhodopsin. J. Biol. Chem. 266:4269-4275 (1991).
14. Cullen, B. R. Use of eukaryotic expression technology in the functional analysis of cloned genes, in Guide to Molecular Cloning Techniques (S. L. Berger and A. R. Kimmel, eds.). Academic Press, New York, 684-705 (1987).
15. Sanger F., S. Nicklen, and A. R. Coulson. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5466 (1977).
16. Munson, P. J., and D. Rodbard. LIGAND: a versatile, computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107:220-239 (1980).
17. Strader, C. D., I. S. Sigal, and R. A. F. Dixon. Structural basis of beta-adrenergic receptor function. FASEB J. 3:1825-1831 (1989).
18. Surratt, C. K., P. S. Johnson, A. Moriwaki, B. K. Seidleck, C. J. Blaschank, J. B. Wang, and G. R. Uhl. Mouse opiate receptor: charged transmembrane domain amino acids critical for agonist recognition and intrinsic activity. J. Biol. Chem. 269:20548-20553 (1994).
19. Gether, U., X. Emonds Alt, J. C. Brelierre, T. Fujii, D. Hagiwara, L. Pradier, C. Garret, T. E. Johansen, and T. W. Schwartz. Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptor. Mol. Pharmacol. 45:500-508 (1994).
20. Bluml, K., E. Mutschler, and J. Wess. Functional role in ligand binding and receptor activation of an asparagine residue present in the sixth transmembrane domain of all muscarinic acetylcholine receptors. J. Biol. Chem. 269:18870-18876 (1994).
21. Wess, J., S. Nanavati, Z. Vogel, and R. Maggio. Functional role of proline and tryptophan residues highly conserved among G protein-coupled receptors studied by mutational analysis of the m3 muscarinic receptor. EMBO J. 12:331-338 (1993).
22. Yamano, Y., K. Ohyama, M. Kikyo, T. Sano, Y. Nakagomi, I. Morishima, D.-F. Guo, T. Hamakubo, and T. Inagami. Mutagenesis and the molecular modeling of the rat angiotensin II receptor (ATI). J. Biol. Chem. 270: 14024-14030 (1995).
23. Deleted in proof.
24. 2 bradykinin receptor: examination of the bradykinin binding site by site directed mutagenesis. Agents Actions Suppl. 38:487-496 (1992).
25. Huang, R. R. C., P. P. Viacario, C. D. Strader, and T. M. Fong. Identification of residues involved in ligand binding to the neurokinin-2 receptor. Biochemistry 34:10048-10055 (1995).
26. Daniell, S. J., P. G. Strange, and L. H. Naylor. Site-directed mutagenesis of Tyr417 in the rat D2 dopamine receptor. Biochem. Soc. Trans. 22:S144 (1994).
27. Mizobe, T., M. Maze, V. Lam, S. Suryanarayana, and B. K. Kobilka. Arrangement of transmembrane domains in adrenergic receptors: similarity to bacteriorhodopsin. J. Biol. Chem. 271:2387-2389 (1996).
28. Befort, K., L. Tabbara, D. Kling, B. Maigret, and B. L. Kieffer. Role of aromatic transmembrane residues of the delta-opioid receptor in ligand recognition. J. Biol. Chem. 271:10161-10168 (1996).
29. Fu, D., J. A. Ballesteros, H. Weinstein, J. Chen, and J. A. Javitch. Residues in the seventh membrane-spanning segment of the dopamine D2 receptor accessible in the binding site crevice. Biochemistry 35:11278-11285 (1996).
30. 2A receptors: evidence in favor of a modified ternary complex model. J. Pharmacol. Exp. Ther. 280:576-583 (1997).
31. Perlman, J. H., L. Laakkonen, R. Osman, and M. C. Gershengorn. Distinct roles for arginines in transmembrane helices 6 and 7 of the thyrotropin-releasing hormone receptor. Mol. Pharmacol. 47:480-484 (1995).
32. Baldwin, J. M. The probable arrangement of the helices in G protein-coupled receptors. EMBO J. 12:1693-1703 (1993).
33. Schwartz, T. W. Locating ligand-binding sites in 7TM receptors by protein engineering. Curr. Opin. Biotech. 5:434-444 (1995).